Author | James M. Pauff, MD, PhD

Articles

Treatment of Metastatic Pancreatic Adenocarcinoma: A Review

January 15, 2014

Gemcitabine monotherapy has been the standard of care for patients with metastatic pancreatic cancer for several decades. Despite recent advances in various chemotherapeutic regimens and in the development of targeted therapies, metastatic pancreatic cancer remains highly resistant to chemotherapy.